Home > Insider Trading > Filing (0001209191-21-002345)

Filing Details

Accession Number:: 0001209191-21-002345
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-01-06 18:50:28
Reporting Period:: 2021-01-04

Accepted Time:: 2021-01-06 18:50:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1714899	Denali Therapeutics Inc.	DNLI	Biological Products, (No Disgnostic Substances) (2836)	463872213

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1724311	O. Alexander Schuth	C/O Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco CA 94080	Coo And Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-01-04	1,400	$65.17	613,162	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-04	1,100	$66.58	612,062	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-04	518	$67.78	611,544	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-04	1,067	$69.07	610,477	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-04	9,340	$70.10	601,137	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-04	9,709	$71.03	591,428	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-04	8,531	$72.22	582,897	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-04	4,626	$73.09	578,271	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-04	5,144	$74.01	573,127	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-04	700	$75.61	572,427	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-04	980	$76.41	571,447	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-04	1,472	$77.64	569,975	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-04	7,876	$78.43	562,099	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-04	3,598	$79.78	558,501	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-04	2,817	$81.45	555,684	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-04	7,996	$82.14	547,688	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-04	1,900	$82.96	545,788	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-04	1,226	$84.17	544,562	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Acquisiton	2021-01-04	30,000	$0.00	30,000	$0.00
Common Stock	Stock Option (right to buy)	Acquisiton	2021-01-04	90,000	$0.00	90,000	$70.86

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
30,000			No	4	A	Direct
90,000		2031-01-03	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	10,686	Direct

Footnotes

The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $65.02 to $65.40 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $66.09 to $67.08 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $67.30 to $68.03 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $68.49 to $69.48 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $69.59 to $70.56 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $70.59 to $71.55 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $71.62 to $72.59 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $72.65 to $73.55 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $73.65 to $74.54 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $74.96 to $75.90 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $76.09 to $77.07 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $77.13 to $78.11 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $78.14 to $78.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $79.42 to $80.22 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $80.71 to $81.70 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $81.71 to $82.69 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $82.77 to $83.45 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $84.00 to $84.25 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
25% of the restricted stock units shall vest on January 4, 2022 (the "Vesting Commencement Date") and an additional 25% of the restricted stock units shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.
25% of the shares subject to the option shall vest on January 4, 2022, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.